Literature DB >> 7884856

RNA secondary structure and binding sites for gag gene products in the 5' packaging signal of human immunodeficiency virus type 1.

J Clever1, C Sassetti, T G Parslow.   

Abstract

The selective encapsidation of retroviral RNA requires sequences in the Gag protein, as well as a cis-acting RNA packaging signal (psi site) near the 5' end of the genomic transcript. Gag protein of human immunodeficiency virus type 1 (HIV-1) has recently been found to bind specifically to the HIV-1 psi element in vitro. Here we report studies aimed at mapping features within the genetically defined psi locus that are required for binding of HIV-1 Gag or of its processed nucleocapsid derivative. The full-length HIV-1 Gag (p55) and nucleocapsid (p15) sequences were expressed as glutathione S-transferase (GST) fusion proteins in Escherichia coli. In a gel shift assay containing excess competitor tRNA, affinity-purified GST-p15 and GST-p55 proteins bound to a 206-nucleotide psi RNA element spanning the major splice donor and gag start codons but did not bind to antisense psi transcripts. Quantitative filter-binding assays revealed that both GST-p55 and GST-p15 bound to this RNA sequence with identical affinities (apparent Kd congruent to 5 x 10(-8) M), indicating that all major determinants of psi binding affinity reside within the nucleocapsid portion of Gag. Chemical and RNase accessibility mapping, coupled with computerized sequence analysis, suggested a model for psi RNA structure comprising four independent stem-loops. Filter-binding studies revealed that RNAs corresponding to three of these hypothetical stem-loops can each function as a independent Gag binding site and that each is bound with approximately fourfold-lower apparent affinity than the full-length psi locus. Interaction of Gag with these regions is likely to play a major role in directing HIV-1 RNA encapsidation in vivo.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7884856      PMCID: PMC188876     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Effect of internal viral sequences on the utility of retroviral vectors.

Authors:  D Armentano; S F Yu; P W Kantoff; T von Ruden; W F Anderson; E Gilboa
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

Review 2.  On finding all suboptimal foldings of an RNA molecule.

Authors:  M Zuker
Journal:  Science       Date:  1989-04-07       Impact factor: 47.728

3.  Construction and analysis of deletion mutations in the U5 region of Moloney murine leukemia virus: effects on RNA packaging and reverse transcription.

Authors:  J E Murphy; S P Goff
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

4.  Identification of a binding site for the human immunodeficiency virus type 1 nucleocapsid protein.

Authors:  K Sakaguchi; N Zambrano; E T Baldwin; B A Shapiro; J W Erickson; J G Omichinski; G M Clore; A M Gronenborn; E Appella
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

5.  Lack of competition results in efficient packaging of heterologous murine retroviral RNAs and reticuloendotheliosis virus encapsidation-minus RNAs by the reticuloendotheliosis virus helper cell line.

Authors:  J E Embretson; H M Temin
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

6.  Identification of a signal in a murine retrovirus that is sufficient for packaging of nonretroviral RNA into virions.

Authors:  M A Adam; A D Miller
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

7.  Evidence for interstrand quadruplex formation in the dimerization of human immunodeficiency virus 1 genomic RNA.

Authors:  W I Sundquist; S Heaphy
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

8.  Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein.

Authors:  T Dorfman; J Luban; S P Goff; W A Haseltine; H G Göttlinger
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

9.  Functional sites in the 5' region of human immunodeficiency virus type 1 RNA form defined structural domains.

Authors:  F Baudin; R Marquet; C Isel; J L Darlix; B Ehresmann; C Ehresmann
Journal:  J Mol Biol       Date:  1993-01-20       Impact factor: 5.469

10.  Packaging of human immunodeficiency virus type 1 RNA requires cis-acting sequences outside the 5' leader region.

Authors:  J H Richardson; L A Child; A M Lever
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

View more
  145 in total

1.  Mutations within four distinct gag proteins are required to restore replication of human immunodeficiency virus type 1 after deletion mutagenesis within the dimerization initiation site.

Authors:  C Liang; L Rong; Y Quan; M Laughrea; L Kleiman; M A Wainberg
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

2.  Deletion mutagenesis downstream of the 5' long terminal repeat of human immunodeficiency virus type 1 is compensated for by point mutations in both the U5 region and gag gene.

Authors:  C Liang; L Rong; R S Russell; M A Wainberg
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

3.  Duplication of the primary encapsidation and dimer linkage region of human immunodeficiency virus type 1 RNA results in the appearance of monomeric RNA in virions.

Authors:  J Sakuragi ; T Shioda; A T Panganiban
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

4.  Human immunodeficiency virus types 1 and 2 differ in the predominant mechanism used for selection of genomic RNA for encapsidation.

Authors:  J F Kaye; A M Lever
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

5.  Stabilization of the U5-leader stem in the HIV-1 RNA genome affects initiation and elongation of reverse transcription.

Authors:  N Beerens; F Groot; B Berkhout
Journal:  Nucleic Acids Res       Date:  2000-11-01       Impact factor: 16.971

6.  Sequences downstream of the 5' splice donor site are required for both packaging and dimerization of human immunodeficiency virus type 1 RNA.

Authors:  Rodney S Russell; Jing Hu; Véronique Bériault; Andrew J Mouland; Michael Laughrea; Lawrence Kleiman; Mark A Wainberg; Chen Liang
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

7.  Determinants of the human immunodeficiency virus type 1 p15NC-RNA interaction that affect enhanced cleavage by the viral protease.

Authors:  N Sheng; S C Pettit; R J Tritch; D H Ozturk; M M Rayner; R Swanstrom; S Erickson-Viitanen
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

8.  G-quartets direct assembly of HIV-1 nucleocapsid protein along single-stranded DNA.

Authors:  Sébastien Lyonnais; Robert J Gorelick; Jean-Louis Mergny; Eric Le Cam; Gilles Mirambeau
Journal:  Nucleic Acids Res       Date:  2003-10-01       Impact factor: 16.971

9.  Characterization of the inhibition mechanism of HIV-1 nucleocapsid protein chaperone activities by methylated oligoribonucleotides.

Authors:  Sergiy V Avilov; Christian Boudier; Marina Gottikh; Jean-Luc Darlix; Yves Mély
Journal:  Antimicrob Agents Chemother       Date:  2011-11-14       Impact factor: 5.191

10.  Definition of a high-affinity Gag recognition structure mediating packaging of a retroviral RNA genome.

Authors:  Cristina Gherghe; Tania Lombo; Christopher W Leonard; Siddhartha A K Datta; Julian W Bess; Robert J Gorelick; Alan Rein; Kevin M Weeks
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.